Karyopharm Therapeutics Inc. Uncategorized Contracts & Agreements

34 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Offer Letter, dated December 19, 2024, between the Company and Lori Macomber
Karyopharm Therapeutics Inc.
Biotechnology
2025
Offer Letter, dated as of April 4, 2022, between the Registrant and Reshma Rangwala
Karyopharm Therapeutics Inc.
Biotechnology
2024
Side Letter to Offer Letter, dated October 1, 2020, between the Registrant and Ran Frenkel
Karyopharm Therapeutics Inc.
Biotechnology
2022
Omnibus Amendment to Transaction Documents, dated as of June 23, 2021, by and among the Company, Karyopharm Europe GmbH, Karyopharm Therapeutics (Bermuda) Ltd., HealthCare Royalty...
Karyopharm Therapeutics Inc.
Biotechnology
NY
2021
Amended and Restated Letter Agreement, dated as of April 28, 2021, between the Company and Sharon Shacham, Ph.D., M.B.A
Karyopharm Therapeutics Inc.
Biotechnology
2021
Amended and Restated Letter Agreement, dated as of April 28, 2021, between the Company and Michael Kauffman, M.D., Ph.D
Karyopharm Therapeutics Inc.
Biotechnology
2021
Offer Letter, dated as of April 28, 2021, between the Company and Richard Paulson
Karyopharm Therapeutics Inc.
Biotechnology
2021
Description of Securities Registered under Section 12 of the Exchange Act
Karyopharm Therapeutics Inc.
Biotechnology
2021
Letter Agreement, dated as of October 1, 2020, between the Registrant and Ran Frenkel
Karyopharm Therapeutics Inc.
Biotechnology
2020
Letter Agreement, dated as of August 31, 2020, between the Company and Michael Mason
Karyopharm Therapeutics Inc.
Biotechnology
2020
Amended and Restated Letter Agreement, dated as of August 31, 2020, between the Company and Christopher B. Primiano
Karyopharm Therapeutics Inc.
Biotechnology
2020
Amended and Restated Letter Agreement, dated as of August 31, 2020, between the Company and Sharon Shacham, Ph.D., M.B.A
Karyopharm Therapeutics Inc.
Biotechnology
2020
Amended and Restated Letter Agreement, dated as of August 31, 2020, between the Company and Michael Kauffman, M.D., Ph.D
Karyopharm Therapeutics Inc.
Biotechnology
2020
Amendment No. 1 to the Open Market Sale Agreement, by and between the Company and Jefferies LLC, dated May 5, 2020
Karyopharm Therapeutics Inc.
Biotechnology
2020
Description of Securities Registered under Section 12 of the Exchange Act
Karyopharm Therapeutics Inc.
Biotechnology
2020
Offer Letter, dated February 3, 2019, between the Company and Michael Mason
Karyopharm Therapeutics Inc.
Biotechnology
MA
2019
Open Market Sale AgreementSM, dated August 17, 2018, by and between Karyopharm Therapeutics Inc. and Jefferies LLC
Karyopharm Therapeutics Inc.
Biotechnology
NY
2018
Offer Letter, dated June 7, 2018, by and between the Registrant and Anand Varadan
Karyopharm Therapeutics Inc.
Biotechnology
2018
Offer Letter, dated September 9, 2017, between the Company and Michael Falvey
Karyopharm Therapeutics Inc.
Biotechnology
2017
First Amendment to Letter Agreement
Karyopharm Therapeutics Inc.
Biotechnology
2017
1. Nachtrag zum Geschäftsführer- Anstellungsvertrag
Karyopharm Therapeutics Inc.
Biotechnology
2015
KARYOPHARM THERAPEUTICS INC.
Karyopharm Therapeutics Inc.
Biotechnology
2015
Vereinbarung über die Änderung eines Geschäftsführer-Anstellungsvertrags
Karyopharm Therapeutics Inc.
Biotechnology
2015
KARYOPHARM THERAPEUTICS INC.
Karyopharm Therapeutics Inc.
Biotechnology
2015
Page 2 of 6
Karyopharm Therapeutics Inc.
Biotechnology
2015
Geschäftsführer-Anstellungsvertrag zwischen
Karyopharm Therapeutics Inc.
Biotechnology
2015
KARYOPHARM THERAPEUTICS INC.
Karyopharm Therapeutics Inc.
Biotechnology
2015
KARYOPHARM THERAPEUTICS INC.
Karyopharm Therapeutics Inc.
Biotechnology
2015
KARYOPHARM THERAPEUTICS INC.
Karyopharm Therapeutics Inc.
Biotechnology
2015
[Signatures appear on following page]
Karyopharm Therapeutics Inc.
Biotechnology
2014
KARYOPHARM THERAPEUTICS INC.
Karyopharm Therapeutics Inc.
Biotechnology
2014
KARYOPHARM THERAPEUTICS INC.
Karyopharm Therapeutics Inc.
Biotechnology
2013
KARYOPHARM THERAPEUTICS INC.
Karyopharm Therapeutics Inc.
Biotechnology
MA
2013
KARYOPHARM THERAPEUTICS INC.
Karyopharm Therapeutics Inc.
Biotechnology
2013